Sanofi Active Ingredient Solutions API Supply, Custom Synthesis, API and Pharma Contract Manufacturing Solutions

 

Sanofi Active Ingredient Solutions is a contract development and manufacturing organisation (CDMO) specialising in active pharmaceutical ingredient (API) supply and custom synthesis.

The company is the new branding of Sanofi API third party business. More than 2,000 women and men are developing, manufacturing and supplying API and technological solutions for external customers and partners in 80 countries.

To do so, the company works with passion, pride and rigour, recognising that its products are the key contributor to therapeutic solutions, helping millions of people live life to its full potential, every day, all over the world.

For innovative pharmaceutical companies, from start-ups to big pharma companies, generics pure players and through its catalogue of high-quality active ingredients and its contract development and manufacturing organisation, the company delivers expertise and customised solutions that contribute to the success of your business.

As a global leader, Sanofi Active Ingredient Solutions has been supporting customers for decades with innovative, efficient and safe solutions, high-quality products and premium customer service.

Contract development and manufacturing services for medical drugs

Sanofi Active Ingredient Solutions offers pharmaceutical drug developers in more than 80 countries with API and technological solutions, supporting partners from process development to regulatory submission.

Its expertise covers multiple therapeutic areas for human and animal health, including corticosteroids, hormones, viral vectors, multi-step chemistry, opiates, prostaglandins and high-active products, as well as plasmids, oligosaccharides, peptides, oligosaccharides, biotechnologies and monoclonal antibodies (mAb).

Sanofi Active Ingredient Solutions partners with innovative companies ranging from start-ups to some of the biggest pharmaceutical players. Its catalogue of high-quality APIs and customised CDMO services delivers expertise and contributes to key therapeutic solutions that help millions of people.

The company has been supporting customers for decades with innovative, efficient and safe solutions, as well as high-quality products and customer service. It focuses on the continuous improvement of manufacturing processes to optimise output and meet client expectations.

Sanofi Active Ingredient Solutions’ synthesis API portfolio covers cardiovascular disease, metabolic disorders, analgesics and non-fluorinated glucocorticoids and derivatives (NSAID), as well as central nervous system (CNS) disorders and anaesthetics.

In the corticosteroids and hormones field, the company has more than 60 years of experience, and is a fully integrated corticoids manufacturer.

Clinical supply and commercial manufacturing for the biotech industry

Sanofi Active Ingredient Solutions has been providing biotech customers with services ranging from clinical supply to commercial manufacturing since 1985. Using its dedicated biotech platform, the company has gained a significant track record, working on an average of more than 70 batches per year.

The company has 25 years of experience in the field of oligosaccharides. Sanofi Active Ingredient Solutions’ analytical expertise guarantees purity and quality, while its robust supply chain is widely recognised.

Fermentation technologies, nutraceuticals, vitamins and probiotics

Sanofi Active Ingredient Solutions offers large-volume fermentation services and has proven expertise in nutraceuticals, vitamins and probiotics.

The company meets clients’ specific demands with the highest standards.

It has a long-standing expertise in organic chemistry with specific competencies in complex and long synthesis, as well as supports its customers’ projects from early phases through to validation campaigns.

APIs for human and animal health

Sanofi Active Ingredient Solutions is a world leader in the manufacturing of prostaglandins, with a strong historical background in process development and the scale-up of new chemical entities. Its portfolio includes 18 prostaglandin APIs.

The company’s production lines are multi-purpose, allowing quick and flexible developments and scale-ups, along with constant high quality. It also provides exhaustive regulatory support to its customers.

Sanofi Active Ingredient Solutions is the sole European vitamin B12 manufacturer, while its biotech API catalogue offers 14 APIs, including antibiotics and anti-tuberculosis.

Beyond the APIs, the company has developed a strong customer-oriented policy with a large range of possible specifications and customisations.

Opiates from poppy seeds to APIs

Sanofi Active Ingredient Solutions provides opiates in forms ranging from poppy seeds to APIs.

The company’s portfolio comprises 15 opiate APIs with applications in agronomic research, industrial and agricultural production, and distribution. It grows and harvests 10,000 ha of poppies each year.

Make an enquiry

Press Release

Sanofi and NH TherAGuIX to Produce AGuIX® Nanoparticle in Oncology

AGuIX® is an innovative nanoparticle discovered by NH TherAGuIX, a French start-up based in Lyon and created in 2015 by Géraldine Le Duc and Olivier Tillement.

White Papers

Sanofi Active Ingredient Solution’s Product List 2019

This white paper showcases Sanofi Active Ingredient Solution's product list for 2018.

Address
Sanofi Active Ingredient Solutions

20, avenue Raymond Aron

92160 Antony Cedex

Ile-de-France

France

+33 1 55 71 26 34 +33 1 55 71 23 63 www.activeingredientsolutions-sanofi.com

Sanofi Active Ingredient Solutions Images

Products and Services

Video

Press Release

19 February 2019

AGuIX® is an innovative nanoparticle discovered by NH TherAGuIX, a French start-up based in Lyon and created in 2015 by Géraldine Le Duc and Olivier Tillement.

Read more
2 October 2018

Sanofi CEPiA has announced that the company will now be known as Sanofi Active Ingredient Solutions.

Read more
10 May 2018

Sanofi has announced it will be attending a number of events this year.

Read more
15 May 2017

Sanofi CEPiA has announced a number of upcoming events where the company will be showcasing its products and services.

Read more
19 October 2016

Sanofi has experience with industrial development of all kinds of projects and brings new chemical entities to market.

Read more
19 April 2016

The Life Science Leader magazine has awarded CEPiA-Sanofi as a worldwide CMO Leader for the third year running.

Read more
12 April 2015

CEPIA-Sanofi has been awarded the CMO leadership award within the categories quality, reliability, productivity and innovation by Life Science Leader.

Read more

Regional Offices

Sanofi Active Ingredient Solutions

20, avenue Raymond Aron

92160 Antony Cedex

Ile-de-France

France

+33 1 55 71 26 34 +33 1 55 71 23 63 www.activeingredientsolutions-sanofi.com
CEPiA US and Canada

55 Corporate Drive

08807 Bridgewater

New Jersey

United States of America

+1 908 981 4986
CEPiA Japan

20-2, Nishishinjuku 3-chome

Shinjuku

163-1488 Tokyo

Japan

+81 3 6301 3450
CEPiA Eastern Europe and Turkey

Nitrianska 100

920 27 Hlohovec

Slovakia

+421 33 736 2810
CEPiA India

Aventis House

54/A, Sir Mathuradas Vasanji

400 093 Mumbai

Maharashtra

India

+91 22 28278089
CEPiA China

Floor 30, Phase II, Plaza 66, No.1366 Nanjing

200040 Shanghai

China

+86 21 6288 1616 (Ext. 2804)
CEPiA Eastern Europe and Turkey

130 U Kabelovny

PRAGUE 10

102 37

Prague

Czech Republic

CEPiA China

Kerry Center Tower 3

20F, 1228 Yan’An Road

Jing An District

200040

Shanghai

China

Close
Close
Close